Results 241 to 250 of about 244,160 (267)

United States Food and Drug Administration Regulation of Human Cells, Tissues, and Gene Therapies

Advances in Experimental Medicine and Biology, 2023
exaly  

Pharmacogenomics in the Assessment of Therapeutic Risks versus Benefits: Inside the United States Food and Drug Administration

Pharmacotherapy, 2011
Issam Zineh
exaly  

The United States Food and Drug Administration

2019
openaire   +1 more source

Drug‐Associated Acute Kidney Injury Identified in the United States Food and Drug Administration Adverse Event Reporting System Database

Pharmacotherapy, 2018
Hanna W Rotundo
exaly  

Pharmacogenomic Biomarker Information in Drug Labels Approved by the United States Food and Drug Administration: Prevalence of Related Drug Use

Pharmacotherapy, 2008
Gilbert Burckart
exaly  

Cancer screening in the United States, 2014: A review of current American Cancer Society guidelines and current issues in cancer screening

Ca-A Cancer Journal for Clinicians, 2014
Robert Smith
exaly  

The burden of rare cancers in the United States

Ca-A Cancer Journal for Clinicians, 2017
Carol E Desantis
exaly  

Adverse drug event reports at the United States Food and Drug Administration Center for Veterinary Medicine

Journal of the American Veterinary Medical Association, 2004
Victoria A, Hampshire, Frederick M, Doddy, Lynn O, Post, Teresa L, Koogler, Tina M, Burgess, Priscilla O, Batten, Roderick, Hudson, Dorothy R, McAdams, Margarita A, Brown   +8 more
openaire   +2 more sources

United States Department of Agriculture. Food and Drug Administration

The Analyst, 1930
openaire   +1 more source

Food and Drug Administration, Partner in Drug Development

Ca-A Cancer Journal for Clinicians, 2006
J W Yates
exaly